Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.6978 per EA under NDC 27241013436. Its NADAC has been published 269 times since Feb 10, 2021.
Strength
4 g/9g
Manufacturer
Ajanta Pharma USA Inc.NDC
27241013436
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211119On Market Since
4/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 269 times since Feb 10, 2021, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6978 per EA |
|---|---|
| All-time high | $1.2770 (Sep 15, 2021) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6834 |
| Median price | $0.9309 |
| Average price | $0.9469 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 269 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Ajanta Pharma USA Inc., is $0.6978 per EA (NDC 27241013436), effective Jun 24, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 44.8%. It has been tracked across 269 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Feb 10, 2021, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.2770 (Sep 15, 2021), with a median of $0.9309 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHOLESTYRAMINE PACKET, is $0.6370 per EA — about 9% below CHOLESTYRAMINE PACKET.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 27241013436) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification